(InDevR, Inc.) InDevR has expanded its VaxArray® product portfolio with a new reagent kit to address the 'need for speed' in combating flu viruses with pandemic potential. The VaxArray Influenza Pandemic Hemagglutinin potency test kit is now available for flu vaccines containing H5, H7, and H9 flu subtypes, which includes new H7 vaccines against the deadly avian H7N9 virus. This new potency assay enables rapid determination of immunogenic hemagglutinin in low-dose and adjuvanted flu vaccines.